ORCHPHARMA.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 01:02):

Stats
Today's Volume	12 261.00
Average Volume	113 746
Market Cap	50.50B
EPS	INR0 ( 2024-05-22 )
Next earnings date	( INR0 ) 2024-08-08
Last Dividend	INR3.00 ( 2012-09-13 )
Next Dividend	INR0 ( N/A )
P/E	52.26
ATR14	INR1.241 (0.12%)

Volume Correlation

Long: -0.08 (neutral)

Short: 0.45 (neutral)

Signal:(40.802) Neutral

Orchid Pharma Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Orchid Pharma Limited Correlation - Currency/Commodity

0.01
( neutral )

-0.29
( neutral )

0.39
( neutral )

-0.42
( neutral )

-0.10
( neutral )

Orchid Pharma Limited Financials

Annual	2023
Revenue:	INR8.19B
Gross Profit:	INR2.32B (28.32 %)
EPS:	INR19.06

FY	2023
Revenue:	INR8.19B
Gross Profit:	INR2.32B (28.32 %)
EPS:	INR19.06

FY	2022
Revenue:	INR6.66B
Gross Profit:	INR2.81B (42.24 %)
EPS:	INR11.35

FY	2022
Revenue:	INR5.60B
Gross Profit:	INR2.33B (41.69 %)
EPS:	INR-0.350

Financial Reports:

No articles found.

Orchid Pharma Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Orchid Pharma Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.38 - No dividend growth expected in the near future

Information

First Dividend	INR2.67	2002-07-16
Last Dividend	INR3.00	2012-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	INR36.67	--
Avg. Dividend % Per Year	0.00%	--
Score	2.95	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.38
Div. Directional Score	7.80	--

Next Divdend (Est)
(2024-06-17)

INR0 Estimate 0.00 %

Dividend Stability

0.03 Very Bad

Dividend Score

2.95

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RUCHIRA.NS	Dividend Knight	2023-09-22	Sporadic	12	1.76%
LAXMIMACH.NS	Dividend Junior	2023-07-24	Annually	23	0.36%
EXIDEIND.NS	Dividend Knight	2023-08-01	Annually	22	0.76%
ALKYLAMINE.NS	Dividend Knight	2023-07-04	Annually	17	0.36%
THOMASCOOK.NS	Dividend Junior	2023-08-10	Sporadic	18	0.15%
OMINFRAL.NS	Dividend Junior	2023-09-22	Annually	13	0.78%
INDIANHUME.NS	Dividend Junior	2023-07-21	Annually	23	0.56%
CHEMBOND.NS	Dividend Knight	2023-08-03	Annually	5	1.02%
SHIVALIK.NS	Dividend Junior	2023-09-22	Annually	3	0.03%
MANAKSIA.NS	Ex Dividend Knight	2023-09-14	Annually	17	2.93%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.112	1.500	7.75	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0593	1.200	8.02	9.63	[0 - 0.3]
returnOnEquityTTM	0.0905	1.500	-0.106	-0.158	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.04	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.81	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.025	1.500	5.41	8.12	[0.2 - 2]
debtRatioTTM	0.0868	-1.500	8.55	-10.00	[0 - 0.6]
interestCoverageTTM	5.66	1.000	9.02	9.02	[3 - 30]
operatingCashFlowPerShareTTM	12.63	2.00	5.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	12.63	2.00	3.69	7.37	[0 - 20]
debtEquityRatioTTM	0.115	-1.500	9.54	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.377	1.000	7.05	7.05	[0.2 - 0.8]
operatingProfitMarginTTM	0.113	1.000	9.74	9.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.475	1.000	8.47	8.47	[0.2 - 2]
assetTurnoverTTM	0.527	0.800	9.82	7.85	[0.5 - 2]
Total Score				12.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	55.18	1.000	4.53	0	[1 - 100]
returnOnEquityTTM	0.0905	2.50	-0.0679	-0.158	[0.1 - 1.5]
freeCashFlowPerShareTTM	12.63	2.00	5.79	7.37	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.63	2.00	5.79	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	4.02	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0782	1.000	-0.545	0	[0.1 - 0.5]
Total Score				3.38

Orchid Pharma Limited Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Orchid Pharma Limited

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.